Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022,
Published January 24, 2018 · Recall initiated: December 14, 2017
Summary
FDA records drug Class II recall D-0216-2018, published January 24, 2018 and initiated December 14, 2017. Recalling firm: SHISEIDO AMERICA INC.; Status: Terminated; Reported quantity: N/A; Lot: SKU#: 95167. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- SHISEIDO AMERICA INC.
- Distributor
- Product was distributed nationwide.
- Lot
- SKU#: 95167
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAShiseido Future Solution LX Universal Defense SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% andJanuary 24, 2018
- FDAbareMinerals Broad Spectrum SPF 50 Daily Prep Lotion (zinc oxide 23.8%, titanium dioxide 4.1%), 40 mL/1.35 fl.January 24, 2018
- FDAMefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco Laboratories, Mason, OHJanuary 24, 2018
- FDAePHEDrine Sulfate In 0.9% Sodium Chloride, 5 mg per mL (50 mg per 10 mL), 10 mL Total Volume pre-filledJanuary 24, 2018
- FDAPhenylephrine HCL 100 mcg per mL (1 mg/10 mL) in 0.9% Sodium Chloride 10 mL syringes, PharMEDium Services, LLCJanuary 24, 2018
- FDABrainlab Navigation System Spine & Trauma 3D with component Brainlab DrapeLink Registration Kit for C-armJanuary 17, 2018
Questions about this recall
Was Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022, recalled?
Yes. FDA published recall D-0216-2018 on January 24, 2018. Reported hazard: GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
What should I do if I have this product?
Voluntary: Firm initiated · Letter